Catherine Marle

Catherine Marle has over 30 years of experience in various leadership roles within the pharmaceutical and healthcare industry. Catherine is currently serving as the Chief Executive Officer at TRIO - Translational Research in Oncology since September 2022. Prior to this role, they were the Chief Operating Officer at Enterome from 2019 to July 2022. From 2015 to 2019, they worked at AB Science as the Global Head Clinical Operations. Before that, they held the position of Global Executive Director Sanofi Alliance Management at Covance from 2011 to 2015. Catherine also had an extensive tenure at IQVIA, where they served in multiple leadership roles, including Vice President Operations Europe, Vice President Late Phase, HE&OR Europe, and Executive Director Clinical Development Europe from 1996 to 2011. Catherine began their career at Wyeth Research as the Director Development Europe from 1991 to 1996.

Catherine Marle has a diverse education background. Catherine pursued program development in General Senior Management at INSEAD until 1999. Prior to that, they completed a CESAM degree in Biostatistics for Clinical trials at Université Paris-Est Créteil (UPEC) in 1987. In 1984, they engaged in a research activity in Molecular biology at Institut Pasteur and also attended advanced courses in the same field at Stanford University. Catherine holds a Post-graduate diploma in Molecular biology from Pierre and Marie Curie University, which they earned in 1983. Before that, they obtained a Master of Science degree in Biochemistry & Immunology from the same university in 1982. In 2014, Catherine Marle became Deputy Mayor in Sèvres.